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  We describe a case of microsporidial myositis 
in a healthy man from Thailand. The small subunit rRNA 
sequence of this microsporidium is novel and has a close 
phylogenetic relationship with Endoreticulatus, a genus of 
lepidopteran microsporidia. Myositis could be caused by 
more genera of microsporidia than previously known. 
M
icrosporidia are obligate intracellular eukaryotes 
of broad host range (1). At least 15 species have 
been implicated in human infections. Although few 
microsporidiosis cases have been reported, they have 
emerged as opportunistic infections in patients with HIV 
infection (1). In addition, microsporidiosis has increasingly 
been diagnosed in other immunocompromised patients, 
including those who have received an organ transplant, 
and in immunocompetent persons (1). Various clinical 
manifestations, ranging from localized (diarrhea, 
cholangitis, sinusitis, keratitis) to disseminated (myositis, 
osteomyelitis, encephalitis) infection have been observed, 
depending on the causative agent and host immune 
status (1). We report microsporidial myositis caused by a 
suspected new species of Microsporidium in an otherwise 
healthy man.
The Study
A 43-year-old man (a welder living in Lopburi Province, 
central Thailand) sought treatment at King Chulalongkorn 
Memorial Hospital, Bangkok, on November 30, 2010. 
He had experienced difﬁ  culty in swallowing for 2 weeks. 
Fifteen months before hospital admission, he experienced a 
low-grade fever and generalized muscle pain, especially in 
his lower back and both thighs. Despite several courses of 
medication, hospital, his condition had not improved.
Ten months before admission, weakness of lower and 
upper limbs developed in his proximal muscle, primarily 
on the left side. Two months before admission, his entire 
left leg was swollen, and he was conﬁ  ned to bed. During 
this illness, he had lost ≈29 pounds. He reported no travel 
abroad and had not taken any herbal medications. He did 
not smoke, drank alcohol occasionally, and did not use 
illicit drugs. He had no history of recurring infections 
during childhood and early adulthood. 
Physical examination showed no keratoconjunctivitis, 
but indicated engorged jugular veins and right ventricular 
heave with loud pulmonic valve closure sound. Abdominal 
examination showed no hepatosplenomegaly. Non-pitting 
edema of the entire left leg was observed. Neurologic 
examination showed hyporeﬂ   exic proximal muscle 
weakness of grade III–IV/V in all limbs. Complete blood 
count showed the following:   hematocrit 43.5%, leukocyte 
count 5,230/mm3 (79% neutrophils, 14% lymphocytes, 4% 
eosinophils, and 3% monocytes), platelet count 209,000/
mm3. Liver function test showed the following results: 
total bilirubin 0.34 mg/dL, alkaline phosphatase 57 U/L 
(reference value 42 U/L–121 U/L), aspartate transaminase 
268 U/L (4 U/L–36 U/L), alanine transaminase 101 U/L (4 
U/L–36 U/L), albumin 3.1 g/dL, and creatine phosphokinase 
4,308 U/L (60 U/L–400 U/L). Test results were negative 
for antibody against nuclear antigen and HIV (2 tests, 1 
month apart). CD4 cell count was 368/μL (24%), and serum 
protein electrophoresis showed polyclonal gammopathy. 
Chest radiograph showed pulmonary hypertension 
without signiﬁ  cant pulmonary inﬁ  ltration. Severe pulmonary 
hypertension without left ventricular dysfunction or left-to-
right shunt was evident on electrocardiogram. Computed 
tomographic scan showed an enlarged pulmonary trunk (4 
cm in diameter) and right and left main pulmonary arteries 
(thrombosis was not shown in the lumens). Electromyograph 
showed irritative myopathy without evidence of large-ﬁ  ber 
sensory and motor polyneuropathy. 
A biopsy of left deltoid and both vastus lateralis 
muscles showed necrotizing granulomatous inﬂ  ammation 
without any organisms by Gram, acid-fast bacilli, 
Wright, and Gomori methenamine silver staining. Bone 
marrow biopsy showed normal cellularity with increased 
plasma cells and histiocytes and focal aggregation of 
microsporidial spores with characteristic belt-like stripe 
(Figure 1). A 24-hour urine sample (centrifuged) yielded 
characteristic microsporidial spores on modiﬁ  ed trichrome 
stain, 1.0–1.5 μm × 1.2–2.2 μm, similar to those observed 
in the bone marrow sample. Because of an overgrowth of 
Candida yeast, we did not isolate the organism from the 
urine sample. 
Analysis of the small subunit rRNA gene spanning 
797 bp of DNA from microsporidial spores isolated 
from this patient showed a novel sequence (GenBank 
accession no. JN619406). Phylogenetic reconstruction 
using the maximum-likelihood method placed the 
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patient’s  Microsporidium sp. within the cluster of the 
genera Endoreticulatus, Cystosporogene, and Vittaforma 
(Figure 2) (2). This species has a close phylogenetic 
relationship with Endoreticulatus  spp. Notably, the 
guanine-cytosine content of the SSU rRNA locus of 
microsporidia within the genus Endoreticulatus varied 
from 51.4% to 51.8%, with the base composition distance 
0.001–0.029. However, the small subunit rRNA sequence 
of microsporidium from our patient (GenBank accession 
no. JN619406) contained 52.4% guanine-cytosine, and the 
base composition distance differed from Endoreticulatus 
spp. from 0.094–0.170, making it unlikely that the patient 
was infected with an organism from this genus.
The patient was treated with albendazole (800 mg/d 
continuously). Fever subsided after 1 week of treatment, 
and weakness gradually improved. He was discharged 
on a regimen of oral albendazole (800 mg/1×/d) but died 
unexpectedly from aspiration pneumonia 1 month later. An 
autopsy could not be performed.
Conclusions
Microsporidia can cause either localized or 
disseminated infection in humans. The true prevalence of 
microsporidiosis in humans may be underestimated because 
of asymptomatic infection in most healthy persons, clinician 
unawareness, and difﬁ  culties in diagnosis. Myositis caused 
by microsporidia is rare; only 12 patients (including 
our patient) have been reported in the literature (online 
Appendix Table, wwwnc.cdc.gov/EID/article/18/2/11-
1319-TA1.htm; 3–12). Among these 12 patients, 9 were 
male and 3 were female (age range 4 months to 67 years). 
Patients were from all continents except Europe: United 
States (7 patients), Australia (2), Haiti (1), the Gambia (1), 
and Thailand (1). The patient described here is the ﬁ  rst 
report from Asia. Trachipleistophora sp. (6 patients) is the 
most common causative agent of myositis, followed by 
Brachiola sp. (3 patients), Pleistophora sp., Tubulinosema 
acridophagus  sp., and Microsporidium spp. (1 patient 
each). However, the species of microsporidia originally 
described in 2 reports (5,6) was changed from Pleistophora 
sp. to Trachipleistophora sp. upon reexamination of the 
ultrastructures by electron microscopy.
Although ultrastructural study of the microsporidium 
from this patient has not been performed, the SSU rRNA 
sequence clearly supports the ﬁ  nding that it is a novel 
species, closely related to Endoreticulatus spp. (Figure 2). 
Most patients in previous reports had disseminated infection 
or isolated myositis. The patient described here had 
pulmonary hypertension, likely caused by microsporidia; 
several reports have shown that these organisms can cause 
pulmonary infection (13).
The routes of microsporidial infection are still 
uncertain, but the species that can infect humans have 
been identiﬁ  ed in water sources and in farm, domestic, 
and wild animals. Furthermore, Trachipleistophora spp. 
have been found only in human hosts. However, on the 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012  303
Figure 1. Microsporidium species in bone marrow aspiration 
specimen (Wright stain) from a 43-year-old man, Thailand. 
The image shows focal aggregations of microsporidia-like 
microorganisms with a belt-like stripe (1.0–1.5 μm × 1.2–2.2 μm). 
Original magniﬁ  cation ×100. 
Figure 2. Phylogenetic tree inferred from the small subunit 
rRNA sequences of microsporidia in this study and those in the 
GenBank database by using the maximum-likelihood method as 
implemented in MEGA5.05 software (2). Red circle indicates a 
novel microsporidium identiﬁ  ed in this study (Microsporidium CU) 
that caused myositis. GenBank accession numbers are listed in 
parentheses after each species. Bootstrap percentages >50% 
based on 1,000 replicates are shown on the branches. The tree 
is drawn to scale, with branch lengths measured in the number of 
nucleotide substitutions per site.basis of the feature of bisporous sporophorous vesicles, T. 
anthropophthera was proposed to be related to Telomyxa 
spp., which are parasites of mayﬂ  ies. T. anthropophthera 
was reported to be the causative agent of keratitis in 
an HIV-infected patient from Thailand (14).  Brachiola 
spp. (formerly Nosema spp.) are known to be pathogens 
of several kinds of insects, including mosquitoes (10). 
Pleistophora spp. have been found in ﬁ  sh and reptiles, but 
P. ronneaﬁ  ei has never been identiﬁ  ed in any hosts other 
than humans. Microsporidium spp. that can infect humans 
are M. ceylonensis and M. africanum. Both species were 
reported from the patients with keratitis from Sri Lanka and 
Africa, respectively, although their natural hosts remain 
unknown.
To our knowledge, the microsporidium possessing 
a novel SSU rRNA sequence closely related to 
Endoreticulatus spp. has never been identiﬁ  ed in patients 
with myositis. Notably, certain lepidopteran microsporidia 
can produce various responses in nontarget hosts, from 
refractory to severe infections. Although we have no 
evidence regarding the route or source of this patient’s 
infection, the close phylogenetic relationship of this 
microsporidium and lepidopteran microsporidia suggests 
that these non–blood-sucking insects could be natural 
hosts. Water or foods contaminated with lepidopteran 
insects could not be excluded as the source of infection. 
Likewise, recent reports that Trachipleistophora extenrec 
can cause myositis in anteaters (15) and that Tubulinosema 
sp. can cause myositis in an immunosuppressed patient 
(12) further support the role of insect microsporidia as 
human pathogens. 
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